SCHEMBL8668103

SCHEMBL8668103

CCC[C](Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
AKR1B1 P15121 1/20 0.46
TP53 P04637 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 1/20 0.42
CNR2 P34972 2/20 0.41
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8579814 0.95 CES2 (0.46) CES2CES1AKR1B1TP53MEN1
SCHEMBL8673057 0.86 MEN1 (0.50) CES2CES1AKR1B1TP53MEN1
SCHEMBL8670638 0.85 MEN1 (0.57) CES2CES1TP53MEN1KMT2A
SCHEMBL16990755 0.84 MEN1 (0.57) CES2CES1TP53MEN1KMT2A
SCHEMBL8671811 0.83 MEN1 (0.60) CES2CES1TP53MEN1KMT2A
SCHEMBL1358269 0.81 CES2 (0.46) CES2CES1AKR1B1TP53MEN1
SCHEMBL14780162 0.80 MEN1 (0.57) CES2CES1TP53MEN1KMT2A
SCHEMBL595614 0.80 CES1 (0.50) CES2CES1AKR1B1TP53MEN1
SCHEMBL8145988 0.79 CES2 (0.44) CES2CES1AKR1B1TP53MEN1
SCHEMBL8041566 0.79 ALDH1A1 (0.54) TP53KMT2AL3MBTL1TDP1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
EP-0686151-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-12-13 EP disclosed
EP-0021883-A2 N-acyl-amino acid derivatives and pharmaceutical compositions containing them, intermediates and starting compounds MERRELL TORAUDE ET COMPAGNIE (FR) 1981-01-07 EP disclosed